Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
INSL5,Insulin-like peptide INSL5,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",23329,99,1.15 [0.94-1.39],0.1676336711827335
INSL5,Insulin-like peptide INSL5,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23960,181,1.27 [1.11-1.46],0.0005561352551576
INSL5,Insulin-like peptide INSL5,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23729,1158,1.07 [1.01-1.13],0.0253144637308691
INSL5,Insulin-like peptide INSL5,Chapter I Certain infectious and parasitic diseases,Candidiasis,23992,416,1.11 [1.01-1.23],0.0251884750057927
INSL5,Insulin-like peptide INSL5,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23249,3047,1.10 [1.07-1.14],3.601589030435969e-08
INSL5,Insulin-like peptide INSL5,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23455,2465,1.12 [1.08-1.17],5.7005505828594495e-09
INSL5,Insulin-like peptide INSL5,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23740,1172,1.19 [1.12-1.26],9.861854321311051e-10
INSL5,Insulin-like peptide INSL5,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23890,81,1.39 [1.14-1.69],0.0011751180601857
INSL5,Insulin-like peptide INSL5,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22407,693,1.16 [1.07-1.24],0.0001035728093055
INSL5,Insulin-like peptide INSL5,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21640,790,1.24 [1.16-1.32],2.689096359233193e-10
INSL5,Insulin-like peptide INSL5,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,21699,219,1.21 [1.06-1.37],0.0040062761708665
INSL5,Insulin-like peptide INSL5,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16811,1425,1.17 [1.11-1.23],4.6791307289376394e-09
INSL5,Insulin-like peptide INSL5,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21509,317,1.26 [1.14-1.40],1.3758282846217206e-05
INSL5,Insulin-like peptide INSL5,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23929,1361,1.19 [1.13-1.25],3.86035710942467e-11
INSL5,Insulin-like peptide INSL5,Chapter I Certain infectious and parasitic diseases,Mycoses,24045,469,1.13 [1.03-1.23],0.0071783876042417
INSL5,Insulin-like peptide INSL5,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23391,820,1.11 [1.03-1.18],0.003219209412715
INSL5,Insulin-like peptide INSL5,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23992,762,1.15 [1.07-1.23],8.188730952787436e-05
INSL5,Insulin-like peptide INSL5,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22749,181,1.29 [1.12-1.47],0.000322575290096
INSL5,Insulin-like peptide INSL5,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,24100,38,1.05 [0.76-1.45],0.7490262974116442
INSL5,Insulin-like peptide INSL5,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23902,672,1.14 [1.06-1.23],0.0006382407932102
INSL5,Insulin-like peptide INSL5,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23884,75,1.18 [0.95-1.47],0.1258790367057267
INSL5,Insulin-like peptide INSL5,Chapter I Certain infectious and parasitic diseases,Other viral diseases,24017,170,1.04 [0.90-1.21],0.5935196109030954
INSL5,Insulin-like peptide INSL5,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",24002,155,1.02 [0.87-1.19],0.8321211244959161
INSL5,Insulin-like peptide INSL5,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22867,296,1.09 [0.97-1.22],0.154434407738472
INSL5,Insulin-like peptide INSL5,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22798,227,1.04 [0.91-1.18],0.6051061019377669
INSL5,Insulin-like peptide INSL5,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22668,100,1.26 [1.05-1.51],0.0150380399775642
INSL5,Insulin-like peptide INSL5,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,24077,33,0.89 [0.62-1.28],0.5215063824862527
INSL5,Insulin-like peptide INSL5,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,24033,139,1.18 [1.00-1.38],0.0451868001062893
INSL5,Insulin-like peptide INSL5,Chapter I Certain infectious and parasitic diseases,Viral warts,23933,39,1.23 [0.91-1.65],0.1806395885139958
INSL5,Insulin-like peptide INSL5,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23964,70,1.07 [0.84-1.35],0.5826783738525949
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,Benign lipomatous neoplasm,23856,207,1.08 [0.95-1.24],0.2396033467820091
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,24007,61,1.01 [0.78-1.30],0.9644164445199755
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,24000,59,1.11 [0.87-1.43],0.3962017921711342
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23847,1057,1.12 [1.06-1.19],0.0001140896980793
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,Benign neoplasm of meninges,24076,75,0.89 [0.70-1.14],0.3488193476252907
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,24042,61,1.02 [0.79-1.32],0.873097388606012
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,24068,114,0.95 [0.78-1.15],0.5853876069346966
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,Benign neoplasm of ovary,24030,152,0.84 [0.70-1.00],0.0481748836711568
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,Benign neoplasm: Ascending colon,24080,238,1.18 [1.05-1.34],0.0068297875140394
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,Benign neoplasm: Caecum,24086,221,1.02 [0.89-1.17],0.7288240751326382
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",24022,57,1.20 [0.94-1.54],0.1385156200783416
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,Benign neoplasm: Descending colon,24084,134,1.50 [1.29-1.74],9.710651222845437e-08
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,Benign neoplasm: Rectum,24046,243,1.16 [1.03-1.31],0.0168325406100092
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,24002,440,1.16 [1.05-1.27],0.0019144169315605
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,Benign neoplasm: Transverse colon,24085,250,1.22 [1.08-1.37],0.0012603288800804
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,Carcinoma in situ of breast,19501,122,1.10 [0.92-1.32],0.2812291224618614
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19573,142,1.12 [0.95-1.32],0.1602583633911596
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",19567,30,1.09 [0.76-1.57],0.6296176461696745
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",19594,57,1.12 [0.87-1.45],0.3693056396530422
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",24039,125,0.99 [0.82-1.19],0.9180057188873648
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,"Haemangioma, any site",24040,123,1.01 [0.84-1.21],0.9278381442864576
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,Leiomyoma of uterus,23220,507,0.99 [0.91-1.09],0.8694191542652469
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,Lung cancer and mesothelioma,17302,283,1.11 [0.99-1.25],0.0783334080521409
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,Lymphoid leukaemia,19571,34,1.27 [0.92-1.75],0.1422283557648954
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19694,157,1.00 [0.85-1.18],0.9877584436559488
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",19632,95,1.03 [0.84-1.27],0.7854054010691504
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19705,168,1.23 [1.07-1.42],0.0039857490818978
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",19597,60,1.14 [0.89-1.46],0.2941497466845855
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",19599,62,1.02 [0.79-1.31],0.8960712128270542
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",19585,48,1.03 [0.77-1.38],0.8325226377950234
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19666,129,1.06 [0.89-1.27],0.5068482849697157
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",19630,93,1.00 [0.81-1.23],0.9919951506706288
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",19611,74,1.41 [1.14-1.73],0.0011743751592457
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",19573,36,1.25 [0.92-1.70],0.1497193220193766
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,19608,71,0.88 [0.68-1.13],0.3083547285516657
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,Melanocytic naevi,23865,207,0.92 [0.79-1.06],0.2546402698891379
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,Melanocytic naevi of trunk,24059,69,0.97 [0.76-1.25],0.8359123171837544
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,Melanoma in situ,19566,77,0.83 [0.64-1.07],0.1425901670386004
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",19608,71,1.08 [0.86-1.36],0.5143989255732693
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19671,134,1.11 [0.93-1.31],0.2393380452074386
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",19744,207,1.17 [1.02-1.33],0.0236499064539333
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",19619,82,1.14 [0.92-1.41],0.2248047345297621
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,Other benign neoplasms of skin,23902,153,1.03 [0.88-1.21],0.7350081471275776
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",20351,814,1.09 [1.02-1.17],0.0114750697319912
INSL5,Insulin-like peptide INSL5,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",20387,850,1.09 [1.02-1.17],0.0103946941668883
INSL5,Insulin-like peptide INSL5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23815,338,1.15 [1.03-1.27],0.0091930089634624
INSL5,Insulin-like peptide INSL5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22367,85,1.27 [1.04-1.55],0.0198958433301022
INSL5,Insulin-like peptide INSL5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23548,71,1.27 [1.02-1.57],0.0321101601662012
INSL5,Insulin-like peptide INSL5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23214,2582,1.06 [1.02-1.10],0.0024866178827695
INSL5,Insulin-like peptide INSL5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22686,27,0.76 [0.49-1.17],0.2101995121796125
INSL5,Insulin-like peptide INSL5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23750,46,1.49 [1.16-1.91],0.0018389173142933
INSL5,Insulin-like peptide INSL5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23589,1307,1.09 [1.04-1.15],0.0013487102421909
INSL5,Insulin-like peptide INSL5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23589,1307,1.09 [1.04-1.15],0.0013487102421909
INSL5,Insulin-like peptide INSL5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22349,67,1.37 [1.10-1.71],0.0043338712638012
INSL5,Insulin-like peptide INSL5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23739,1080,1.05 [0.99-1.12],0.1025765404959933
INSL5,Insulin-like peptide INSL5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23807,103,0.96 [0.79-1.18],0.7222130107068695
INSL5,Insulin-like peptide INSL5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23522,45,0.97 [0.72-1.32],0.8643042286133957
INSL5,Insulin-like peptide INSL5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23531,54,0.94 [0.71-1.25],0.6893838989748704
INSL5,Insulin-like peptide INSL5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23914,210,1.07 [0.93-1.23],0.3316118100982079
INSL5,Insulin-like peptide INSL5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,24006,54,1.04 [0.80-1.35],0.7741611390120853
INSL5,Insulin-like peptide INSL5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23882,178,1.02 [0.87-1.18],0.8458690631691776
INSL5,Insulin-like peptide INSL5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22774,115,1.35 [1.14-1.59],0.0005303539308126
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,19439,211,1.56 [1.39-1.75],3.389320924254652e-14
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22851,59,1.37 [1.09-1.72],0.0067183277882179
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22847,55,1.98 [1.64-2.39],1.098102099611911e-12
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,19272,44,1.56 [1.20-2.03],0.0007636554741368
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22102,54,1.15 [0.89-1.48],0.2898703673795471
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21819,207,1.20 [1.05-1.37],0.0068039921655672
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23712,422,1.10 [1.00-1.21],0.0534118441864122
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23555,265,1.08 [0.95-1.22],0.2292475585604032
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,23351,61,0.92 [0.70-1.20],0.5290602938339641
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23764,1716,1.03 [0.98-1.08],0.2088446980649999
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21372,1678,1.04 [0.99-1.09],0.1632597498486158
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",19275,47,1.14 [0.86-1.52],0.3594623970181785
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",21433,103,1.04 [0.85-1.27],0.6906436772967527
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,19473,245,1.26 [1.12-1.42],0.0001438688754106
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,19270,42,1.07 [0.79-1.46],0.6557824654918143
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21974,2746,1.10 [1.06-1.15],2.3242778593747786e-07
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,19409,181,1.35 [1.18-1.55],1.4302513254414802e-05
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,19698,470,1.24 [1.14-1.35],1.2671815731428708e-06
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,24015,313,1.14 [1.02-1.27],0.0163728168215388
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23846,144,1.09 [0.93-1.28],0.3027238855327017
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,19317,89,1.15 [0.93-1.41],0.190537549763207
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",19277,49,1.06 [0.79-1.42],0.690743969380613
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23336,2006,1.01 [0.97-1.06],0.5782006807143405
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,19404,176,1.44 [1.26-1.65],5.5601726786293455e-08
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,19400,172,1.46 [1.28-1.67],1.641558962245235e-08
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",19696,468,1.11 [1.01-1.22],0.0241584866074589
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,19299,71,1.36 [1.09-1.68],0.0056405274483359
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23840,138,1.08 [0.92-1.27],0.3603706795102753
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,19767,539,1.10 [1.01-1.20],0.0245383046688799
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,19711,483,1.10 [1.00-1.20],0.0481894980178132
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21675,63,1.08 [0.84-1.38],0.5489029240872869
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23328,4100,1.10 [1.07-1.14],2.1684607575861147e-10
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,21393,63,1.02 [0.79-1.31],0.9068189301272542
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,21405,75,1.13 [0.91-1.41],0.2743182376135068
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23933,1789,1.03 [0.98-1.08],0.2606031784709771
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23936,1788,1.03 [0.98-1.08],0.2777312640294413
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,21404,74,0.92 [0.73-1.17],0.5179655806371584
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23736,1382,1.07 [1.02-1.13],0.0098824710384832
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20532,1304,1.18 [1.12-1.24],1.5557268589827503e-09
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,24089,155,1.35 [1.18-1.56],2.2683513416672782e-05
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,23331,41,1.11 [0.82-1.50],0.5163055746630105
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22474,120,0.96 [0.79-1.16],0.6547991252257059
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22525,171,0.91 [0.77-1.06],0.2252926668786706
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",19446,218,1.12 [0.98-1.28],0.0889484446182535
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22505,120,1.31 [1.11-1.54],0.0014015026837029
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1487,38,1.17 [0.88-1.57],0.2856810096364631
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1581,150,1.14 [0.98-1.32],0.0860382437789352
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22409,24,1.78 [1.26-2.51],0.0010243189261216
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1472,24,1.06 [0.74-1.53],0.754066582822774
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23691,1306,1.24 [1.18-1.31],4.6324071740339016e-17
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23584,294,1.09 [0.97-1.22],0.1618049628272786
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,22034,422,1.12 [1.02-1.24],0.0139316276271981
INSL5,Insulin-like peptide INSL5,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,19851,623,1.12 [1.04-1.22],0.0032207308079147
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",24011,208,1.08 [0.95-1.24],0.2479519625841103
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),23205,44,0.89 [0.65-1.23],0.487733434576073
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Angina pectoris,22758,756,1.04 [0.97-1.12],0.243518154895922
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Aortic aneurysm,23241,80,0.85 [0.66-1.08],0.1807820866325002
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,23190,29,1.31 [0.94-1.83],0.1069548030074533
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",23299,138,1.16 [0.98-1.36],0.0799459395087212
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,15640,1269,1.12 [1.06-1.19],2.995400640874329e-05
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,AV-block,21142,213,1.14 [0.99-1.30],0.0613212743425079
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",24058,267,1.13 [1.00-1.27],0.0412942735518282
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Cardiac arrest,14479,108,1.22 [1.02-1.47],0.0306355201929887
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Cardiomyopathy,21047,118,1.09 [0.91-1.31],0.3543591719527951
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",20999,70,1.23 [0.98-1.54],0.0718165556814883
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,24096,27,1.41 [1.00-1.97],0.0480587590788933
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Conduction disorders,21565,636,1.11 [1.03-1.20],0.0060763917995429
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23294,1303,1.07 [1.01-1.13],0.0158108650096591
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,21689,6403,1.06 [1.04-1.09],1.7789891821490206e-06
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22790,221,1.06 [0.93-1.22],0.3601265964808644
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Endocarditis,20974,45,1.28 [0.97-1.69],0.0809742413473261
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,"Heart failure, strict",24012,726,1.19 [1.11-1.28],7.173059162573878e-07
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Hypertension,22238,5389,1.08 [1.05-1.11],1.0988635206763903e-08
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,"Hypertension, essential",22246,5397,1.08 [1.05-1.11],4.899957373210283e-09
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,"Hypertension, portal",24000,34,1.25 [0.91-1.72],0.1598101599629229
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",17000,151,1.27 [1.09-1.48],0.0022889900883648
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16917,68,1.91 [1.58-2.31],2.8792808036061408e-11
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Hypotension,23984,926,1.07 [1.00-1.14],0.0459429473128386
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,23440,85,1.16 [0.94-1.42],0.1693741119849117
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23476,1474,1.06 [1.00-1.11],0.0329867865160405
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23826,397,1.04 [0.94-1.15],0.4518494134111165
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Left bundle-branch block,21199,270,1.12 [0.99-1.26],0.0697360886869297
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23907,526,1.05 [0.96-1.15],0.2633497192817615
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22423,421,1.06 [0.96-1.16],0.2696044969974648
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",24075,78,0.94 [0.74-1.19],0.5907092733900452
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",24092,208,1.07 [0.93-1.22],0.3545568116810857
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Oesophageal varices,22602,33,1.44 [1.06-1.96],0.0187491880931456
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Other aneurysm,23211,50,1.04 [0.78-1.39],0.7799608408762719
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Other arrhythmias,21247,318,1.09 [0.98-1.22],0.1176384756915017
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,23221,60,1.34 [1.07-1.69],0.0119448078664615
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23334,173,1.29 [1.12-1.48],0.0003345295660975
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,21074,145,1.03 [0.87-1.22],0.6942160526689799
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Other disorders of veins,22646,77,1.02 [0.82-1.28],0.8444086875927689
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22610,41,1.09 [0.81-1.48],0.5659810605569711
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,23006,32,0.99 [0.69-1.43],0.9729211015340272
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22707,138,1.04 [0.88-1.23],0.627236938689154
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21602,673,1.18 [1.10-1.27],7.447327938888569e-06
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,23095,37,1.34 [0.99-1.80],0.0551526528951658
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23608,447,1.09 [0.99-1.19],0.0804217947642879
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23586,288,1.16 [1.04-1.30],0.0080526080816394
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",23446,472,1.11 [1.02-1.21],0.0214254300589657
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14627,256,1.07 [0.95-1.22],0.2756575538983051
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23394,244,1.14 [1.01-1.28],0.0412502337301714
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22858,289,1.03 [0.92-1.16],0.59316227722926
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23689,391,1.04 [0.94-1.15],0.4281347920957918
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,24027,502,1.09 [1.00-1.19],0.043448800590524
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Right bundle-branch block,21114,185,1.15 [0.99-1.32],0.0591785325654562
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23579,281,1.17 [1.04-1.31],0.0064769785537274
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,23108,134,1.04 [0.88-1.24],0.651002411793624
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23817,462,1.07 [0.97-1.17],0.1740638107881318
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23793,503,1.05 [0.97-1.15],0.2387538449435622
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,23410,63,0.85 [0.64-1.11],0.230822324328244
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,23198,37,0.98 [0.69-1.38],0.89720464295932
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23614,185,0.90 [0.77-1.05],0.1784540216193509
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23557,176,1.04 [0.90-1.21],0.6020002802485129
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Varicose veins,22956,387,1.02 [0.92-1.13],0.7554630887889225
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,23172,84,0.79 [0.62-1.01],0.0581698634270941
INSL5,Insulin-like peptide INSL5,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23914,617,1.04 [0.96-1.12],0.390029940107811
INSL5,Insulin-like peptide INSL5,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",24062,196,1.57 [1.39-1.77],1.695203716819805e-13
INSL5,Insulin-like peptide INSL5,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21415,1614,1.06 [1.01-1.12],0.013610365565672
INSL5,Insulin-like peptide INSL5,Chapter V Mental and behavioural disorders,Any mental disorder,23576,3775,1.05 [1.02-1.09],0.0014483630432914
INSL5,Insulin-like peptide INSL5,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",24036,233,1.52 [1.36-1.70],1.4519654918311616e-13
INSL5,Insulin-like peptide INSL5,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21534,1733,1.04 [0.99-1.09],0.1135811939426818
INSL5,Insulin-like peptide INSL5,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19879,78,1.19 [0.96-1.47],0.1187714676395095
INSL5,Insulin-like peptide INSL5,Chapter V Mental and behavioural disorders,Smoking dependency,23744,1042,1.06 [0.99-1.12],0.08357736215481
INSL5,Insulin-like peptide INSL5,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21010,1209,1.12 [1.06-1.18],0.0001052142007439
INSL5,Insulin-like peptide INSL5,Chapter V Mental and behavioural disorders,Vascular dementia,23669,92,1.18 [0.97-1.44],0.0990044625779662
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Alzheimer disease,24098,328,1.06 [0.95-1.18],0.3083751523990358
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",16503,53,1.04 [0.79-1.37],0.7616069898679233
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Bell's palsy,22216,72,1.03 [0.82-1.30],0.7982800732413996
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22702,558,1.03 [0.95-1.12],0.4822041106797271
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Cerebral cysts,23748,190,1.01 [0.87-1.16],0.9389655194414116
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,24033,237,1.00 [0.88-1.14],0.9785245861502436
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23671,39,0.98 [0.70-1.35],0.882592256177444
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,24088,44,1.17 [0.88-1.56],0.2667340071065831
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23602,44,0.97 [0.71-1.32],0.8402422994071422
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Epilepsy,22816,246,1.01 [0.89-1.15],0.8572994937648699
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23729,1159,0.99 [0.94-1.05],0.839880670163359
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,24054,311,0.93 [0.83-1.05],0.239336502784249
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23553,2541,1.06 [1.02-1.11],0.0016807228340966
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Generalized epilepsy,23780,42,0.89 [0.64-1.23],0.4765831573449313
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Hemiplegia,23984,188,1.04 [0.90-1.20],0.6395521649429714
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Hydrocephalus,23614,56,0.83 [0.62-1.11],0.1991616229997333
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,24081,67,1.08 [0.85-1.37],0.5291129995454469
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22255,111,0.96 [0.79-1.17],0.669643901630749
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22199,55,1.25 [0.97-1.60],0.0796111795861243
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Memory loss,23557,93,1.24 [1.02-1.51],0.0283851903505744
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Migraine,23016,446,0.92 [0.84-1.02],0.1162748751902723
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23997,404,0.94 [0.85-1.04],0.2207314827460872
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Motor neuron disease,16591,116,0.89 [0.73-1.08],0.2377503722332599
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23897,124,0.82 [0.68-1.00],0.0557753126777389
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23364,1220,1.03 [0.97-1.09],0.294162383562058
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Neurological diseases,22676,3253,1.00 [0.97-1.04],0.8767192232941684
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23756,124,1.00 [0.83-1.19],0.9603912928158568
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22515,371,0.99 [0.89-1.10],0.8452731637035659
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",24045,194,1.13 [0.99-1.30],0.0750604945594659
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19484,583,1.00 [0.92-1.08],0.9296228454696314
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23617,59,1.11 [0.86-1.43],0.4115144926609901
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23668,110,0.84 [0.69-1.03],0.0973740888074651
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23886,143,0.93 [0.78-1.11],0.4048914372764308
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22224,80,1.03 [0.83-1.29],0.7849208996799969
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Other headache syndromes,22639,69,0.78 [0.60-1.02],0.0727466931306785
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Other neurological diseases,23997,439,0.97 [0.88-1.07],0.5368594497316475
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Other sleep disorders,22916,346,1.12 [1.01-1.24],0.0310380670916735
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Parkinson's disease,24075,147,0.91 [0.77-1.09],0.3068351095509618
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23631,73,1.07 [0.84-1.35],0.5944007987088826
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Restless leg syndrome,24097,76,0.79 [0.61-1.02],0.06875927272079
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Sleep apnoea,23943,278,1.13 [1.01-1.27],0.0309825616383754
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23885,34,1.52 [1.14-2.03],0.0046446804063703
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,24088,141,0.96 [0.81-1.15],0.6809320683003037
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22206,62,1.06 [0.83-1.36],0.6450005609571916
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,24098,331,1.05 [0.94-1.17],0.357457221210997
INSL5,Insulin-like peptide INSL5,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23628,89,1.18 [0.96-1.44],0.1119134280205546
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23581,93,0.93 [0.75-1.15],0.4816533410499312
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23695,428,0.91 [0.82-1.01],0.0798634089580459
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23971,141,1.25 [1.08-1.45],0.0033555583587963
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,23127,52,0.96 [0.72-1.28],0.7999665632570863
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23122,47,0.86 [0.63-1.19],0.3636367380702855
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23989,57,0.86 [0.65-1.13],0.2793493609616989
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23849,148,1.08 [0.92-1.27],0.3258497623217687
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1478,29,1.04 [0.74-1.45],0.8298243845117872
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1769,56,1.02 [0.79-1.31],0.8870812066737592
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23572,84,0.92 [0.73-1.16],0.4819845556777008
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23949,919,1.01 [0.95-1.08],0.6700725063352883
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23725,650,1.02 [0.94-1.10],0.6053734158997238
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23336,261,0.95 [0.83-1.08],0.4135258858220761
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",24022,755,0.96 [0.89-1.03],0.2673438161815367
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,24086,62,1.31 [1.04-1.64],0.022401267462992
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23955,688,0.97 [0.90-1.05],0.4199478521362674
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",24060,359,1.05 [0.95-1.17],0.328516034824899
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,24016,184,1.06 [0.92-1.23],0.4259117439484071
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23113,38,1.12 [0.82-1.54],0.4776855930445935
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23117,42,1.28 [0.97-1.70],0.0819862313833262
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,23137,62,1.05 [0.81-1.35],0.7197949325357582
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,24018,624,0.94 [0.87-1.03],0.1721195479157407
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23546,152,0.97 [0.82-1.15],0.7303695523059817
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23325,58,0.87 [0.66-1.15],0.3352317267525715
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23791,90,1.05 [0.85-1.29],0.6793804213587252
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23979,278,1.08 [0.96-1.22],0.1763511405887544
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23451,184,1.00 [0.86-1.16],0.9960756765300992
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23950,118,1.01 [0.83-1.21],0.9493129313064964
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23801,407,0.96 [0.87-1.07],0.4602419453094105
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23627,139,1.04 [0.88-1.23],0.6834140114966285
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22523,2236,0.98 [0.94-1.03],0.4461224177236693
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23947,246,1.09 [0.96-1.23],0.1986808546546181
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,24076,144,1.10 [0.93-1.29],0.2521945399032637
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23410,335,1.05 [0.94-1.17],0.3980231821901658
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23759,58,1.06 [0.82-1.38],0.6541829192651858
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,24073,49,1.26 [0.97-1.64],0.0808258540708212
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23158,83,0.93 [0.74-1.17],0.5532257081964256
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23203,128,0.97 [0.81-1.16],0.7110676931122325
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,23125,95,1.09 [0.89-1.33],0.4186648998430611
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23325,58,0.77 [0.57-1.04],0.0838677681526386
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",23087,57,0.93 [0.71-1.23],0.6264023653320839
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23500,106,0.92 [0.75-1.13],0.4190662359188979
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23551,157,0.90 [0.77-1.07],0.2421268853194824
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23185,110,1.02 [0.84-1.23],0.8701432113438397
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,23112,82,0.99 [0.79-1.25],0.960360708487418
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,23089,59,0.97 [0.74-1.26],0.820162295565649
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,22121,1834,0.98 [0.93-1.03],0.3517834504917612
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23151,76,1.11 [0.89-1.39],0.3533723548572861
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23868,380,0.96 [0.87-1.07],0.4631948168514183
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23528,40,1.02 [0.74-1.40],0.917047138924832
INSL5,Insulin-like peptide INSL5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23636,148,1.21 [1.04-1.41],0.0139862849837423
INSL5,Insulin-like peptide INSL5,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23872,103,1.05 [0.86-1.27],0.6587388953258663
INSL5,Insulin-like peptide INSL5,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,24056,93,0.94 [0.76-1.16],0.5566675446097529
INSL5,Insulin-like peptide INSL5,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23989,129,1.06 [0.90-1.26],0.4825759294255236
INSL5,Insulin-like peptide INSL5,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23833,64,0.94 [0.73-1.22],0.6363799409680997
INSL5,Insulin-like peptide INSL5,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,23835,66,1.09 [0.85-1.38],0.5053183905679451
INSL5,Insulin-like peptide INSL5,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,24003,708,0.99 [0.91-1.07],0.7312633054240583
INSL5,Insulin-like peptide INSL5,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23777,482,0.97 [0.89-1.07],0.5768082803317818
INSL5,Insulin-like peptide INSL5,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,23397,102,1.05 [0.87-1.28],0.6101864429658277
INSL5,Insulin-like peptide INSL5,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,23371,76,1.00 [0.79-1.26],0.991495060200596
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Acute pharyngitis,23850,74,1.07 [0.85-1.34],0.5798397903528576
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23985,209,0.94 [0.82-1.09],0.4278758920321517
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23833,57,0.99 [0.75-1.29],0.9263457986691233
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,All influenza,22604,114,1.16 [0.97-1.38],0.1084212868554861
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22603,113,1.17 [0.98-1.40],0.0891832950600435
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Allergic asthma (mode),17133,114,1.07 [0.88-1.28],0.50587525448337
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Allergic rhinitis,23972,250,0.95 [0.84-1.09],0.4771618242627634
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18701,1842,1.11 [1.06-1.16],1.2294991572370128e-05
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18837,1818,1.11 [1.06-1.16],1.333610229727792e-05
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23737,116,1.11 [0.93-1.33],0.2471593439044759
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22551,61,1.05 [0.82-1.35],0.69336867915001
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Bronchiectasis,20810,352,1.15 [1.04-1.28],0.006496008994391
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20519,61,0.98 [0.76-1.27],0.8864920898199626
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23085,2627,1.09 [1.05-1.13],1.8989212287701748e-05
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22978,59,1.07 [0.83-1.39],0.6047479503253393
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Chronic sinusitis,23045,126,0.96 [0.80-1.16],0.6891830061827653
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23944,909,1.09 [1.02-1.16],0.0079864392997513
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Deviated nasal septum,22986,67,0.93 [0.72-1.20],0.5826384869129699
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22251,4518,1.09 [1.06-1.12],6.480811596940473e-09
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",23215,296,1.08 [0.97-1.21],0.1759992407699829
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Early onset COPD,23319,284,1.02 [0.91-1.15],0.7072761161848493
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Emphysema,20689,231,1.14 [1.01-1.30],0.037960770627879
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22628,203,1.02 [0.89-1.18],0.7819987012178489
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23919,1429,1.13 [1.08-1.19],1.2010398166709831e-06
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Interstitial lung disease,22664,239,1.07 [0.94-1.21],0.3280240661395778
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Later onset COPD,23280,625,1.12 [1.03-1.21],0.004702588456016
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,24091,191,1.10 [0.96-1.27],0.1827368520514083
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Nasal polyp,22978,59,1.04 [0.80-1.34],0.7930885994667758
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23898,812,1.10 [1.03-1.18],0.0050945068016936
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Other diseases of pleura,23928,1524,1.14 [1.08-1.20],2.1239685343029365e-07
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23608,689,1.02 [0.94-1.10],0.6588579806304506
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Other pleural conditions,22439,35,1.18 [0.85-1.63],0.3188460072279476
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,24023,303,1.12 [1.00-1.25],0.0413539936986648
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,24015,1038,1.15 [1.08-1.22],6.122070524407146e-06
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Pleural effusion,23127,723,1.15 [1.07-1.23],0.0001377702709592
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Pleural plaque,22445,41,1.04 [0.76-1.42],0.8264371757245258
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23704,1214,1.14 [1.08-1.21],1.4494305857366454e-06
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,24064,164,1.15 [0.99-1.34],0.0690222452611734
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Pneumothorax,22491,87,1.19 [0.97-1.46],0.0994817045180974
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Pollen allergy,24074,210,0.90 [0.78-1.04],0.1586153863949934
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Pulmonary oedema,23774,54,1.28 [1.00-1.63],0.0506508512216796
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Respiratory insufficiency,17063,44,1.48 [1.12-1.94],0.0053897619105342
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23879,793,1.11 [1.03-1.19],0.0036569247403024
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,23169,250,0.95 [0.84-1.09],0.491136366975169
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Viral pneumonia,22675,185,1.16 [1.01-1.34],0.0347361510154376
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23744,146,1.10 [0.94-1.28],0.2575578113043377
INSL5,Insulin-like peptide INSL5,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11603,91,1.16 [0.94-1.41],0.1606115337504433
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,17245,35,1.32 [0.97-1.79],0.0769808273969329
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Acute appendicitis,23931,122,1.00 [0.83-1.20],0.9860272343911608
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Acute gastritis,18102,74,1.04 [0.82-1.32],0.7325178228096483
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Acute pancreatitis,22098,143,1.02 [0.87-1.21],0.785161357256044
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Acute peritonitis,23595,75,1.22 [0.99-1.52],0.0668706384013283
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23345,31,1.72 [1.28-2.30],0.0002801743301897
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Barrett oesophagus,18332,304,0.98 [0.87-1.11],0.774971043958125
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22024,69,1.02 [0.80-1.29],0.8966198642726593
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23726,69,1.01 [0.80-1.29],0.911371359317482
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Cholecystitis,22111,156,0.84 [0.70-0.99],0.0424190994294026
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Cholelithiasis,22998,1043,0.98 [0.92-1.04],0.441358567392946
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Chronic gastritis,18325,297,1.06 [0.94-1.19],0.3379866260614346
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21992,37,1.58 [1.20-2.08],0.0011756447118142
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",24027,61,1.28 [1.02-1.61],0.0352520849838796
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Coeliac disease,22756,123,1.11 [0.93-1.32],0.2649369435258323
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Collagenous colitis,22431,97,1.17 [0.96-1.42],0.1272984708610745
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23973,140,1.40 [1.21-1.63],8.545363958659266e-06
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Constipation,23801,1484,1.00 [0.95-1.05],0.9393046052715304
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Crohn disease,22407,73,1.29 [1.04-1.60],0.0227350795016015
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23778,51,1.41 [1.10-1.81],0.0066808375476141
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22409,75,1.37 [1.11-1.69],0.0030453354943351
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Dental caries,23369,201,1.06 [0.93-1.22],0.3741228190891925
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22667,2140,0.99 [0.95-1.04],0.691100359358119
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Diseases of appendix,23970,161,1.00 [0.85-1.17],0.985131048037814
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Diseases of liver,24011,697,1.15 [1.07-1.24],0.0001397632935544
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22086,4058,1.00 [0.97-1.03],0.8560559721480685
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23684,516,1.08 [0.99-1.18],0.0654524882536261
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23989,469,1.09 [1.00-1.19],0.0573647570898411
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23274,106,0.99 [0.82-1.21],0.940195771748532
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Diseases of salivary glands,23140,58,0.80 [0.60-1.07],0.1314790959867348
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23842,1209,1.06 [1.00-1.12],0.0379086112222188
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Diseases of tongue,23144,92,1.09 [0.89-1.34],0.3855625342604408
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23347,1392,1.00 [0.95-1.06],0.9573851358378168
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20013,2803,1.18 [1.14-1.22],1.0541549471851212e-18
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Duodenal ulcer,18146,118,1.05 [0.87-1.26],0.6275935161963612
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",24049,98,1.02 [0.83-1.25],0.857109575144046
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,24010,55,1.24 [0.97-1.60],0.0871032365630659
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23393,79,1.14 [0.92-1.41],0.2167189105147258
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,17312,102,1.42 [1.19-1.70],8.083093775312817e-05
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Functional dyspepsia,18620,592,0.95 [0.87-1.04],0.2539646483997528
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Gastric ulcer,18332,304,0.97 [0.86-1.09],0.641439662279143
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20473,2445,0.97 [0.93-1.01],0.1828782540776834
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18449,421,1.00 [0.90-1.10],0.9389131564343006
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18862,7386,1.04 [1.02-1.07],0.000995094357159
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,GI-bleeding,23602,969,1.05 [0.98-1.12],0.1387231016873115
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,23229,61,1.05 [0.81-1.35],0.7158342811682905
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,18060,1107,1.10 [1.04-1.17],0.0010284974222929
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23347,33,1.32 [0.97-1.81],0.0770972810057653
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Hernia,23054,2527,1.00 [0.96-1.04],0.9704750775663008
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Impacted teeth,24019,50,1.22 [0.94-1.59],0.136565717525723
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Impaction of intestines,17270,60,1.29 [1.02-1.64],0.0337828629061994
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Inguinal hernia,20674,147,1.03 [0.87-1.21],0.765869791035388
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,17293,83,1.23 [1.00-1.51],0.0498070029160972
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22782,149,1.13 [0.96-1.32],0.1387437977453962
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,17921,711,1.12 [1.04-1.21],0.0018692590334377
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,24088,302,1.30 [1.17-1.44],6.66850598986708e-07
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23053,719,1.17 [1.09-1.25],2.398843656271536e-05
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23300,966,1.14 [1.07-1.21],5.714094213403769e-05
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Oesophageal obstruction,18161,133,1.09 [0.92-1.30],0.3060082337269726
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Oesophagitis,18533,505,1.00 [0.92-1.10],0.9446330520249112
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,24056,140,1.03 [0.87-1.22],0.7571244715209521
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20580,53,1.01 [0.77-1.33],0.9275915217502148
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,18315,1105,1.05 [0.99-1.11],0.1201865050216932
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22213,258,0.99 [0.87-1.12],0.8768302683542973
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22120,165,1.08 [0.93-1.26],0.3205391175788297
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Other diseases of intestine,18599,1389,1.12 [1.06-1.18],1.7233975746002045e-05
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Other diseases of intestines,22198,4988,1.10 [1.07-1.13],9.32483428299365e-11
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,23142,201,1.06 [0.92-1.21],0.4547468490922922
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Other diseases of liver,23895,581,1.17 [1.08-1.26],9.58166134704866e-05
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18550,522,0.99 [0.90-1.08],0.764038704511538
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22093,138,0.98 [0.82-1.17],0.8102044409597086
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23931,411,1.06 [0.96-1.17],0.2274271484406954
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18975,947,0.98 [0.92-1.05],0.5893069014245473
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23619,986,1.04 [0.98-1.11],0.1789577371586886
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23322,154,0.98 [0.83-1.16],0.8276390096793551
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18746,1536,1.03 [0.98-1.09],0.2346442554224742
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19872,1844,0.98 [0.93-1.03],0.4176523714511585
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23402,88,1.06 [0.86-1.31],0.5794607664520848
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23187,853,1.16 [1.09-1.24],8.119880575292105e-06
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17505,295,1.17 [1.05-1.31],0.0052326989074889
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,24000,64,1.26 [1.00-1.59],0.0493422568043613
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17645,435,1.10 [1.00-1.21],0.0547993867575992
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22754,121,1.18 [0.99-1.40],0.062612691464698
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Recurring oral aphthae,24090,63,1.27 [1.01-1.60],0.0403756402545928
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,23169,116,1.18 [0.99-1.40],0.0716940018539886
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Toxic colitis,22390,56,1.25 [0.97-1.61],0.0841250544218883
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,18237,209,1.20 [1.05-1.37],0.0068088786282271
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Ulcerative colitis,22484,150,0.94 [0.79-1.12],0.4839270032755706
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22460,126,0.96 [0.80-1.16],0.6604926082740774
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Umbilical hernia,20681,154,1.07 [0.92-1.25],0.3757485439434993
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,17380,170,0.88 [0.74-1.03],0.1155296959530389
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Ventral hernia,20749,222,1.00 [0.88-1.15],0.9801457080530034
INSL5,Insulin-like peptide INSL5,Chapter XI Diseases of the digestive system,Volvulus,17284,74,0.89 [0.69-1.14],0.3506322642689879
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,24024,217,1.00 [0.87-1.15],0.9527281335340826
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23818,74,1.03 [0.81-1.29],0.832745719620857
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22295,199,0.99 [0.86-1.15],0.9443415456376918
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23619,552,1.19 [1.10-1.29],2.31104424248373e-05
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23198,131,1.13 [0.95-1.33],0.1582808097155211
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22378,282,1.18 [1.05-1.32],0.0041775642871981
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23822,249,1.16 [1.03-1.31],0.0161196562104699
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,24000,427,1.09 [0.99-1.20],0.0707365178764155
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23617,44,0.99 [0.73-1.34],0.925460418690628
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22700,2789,1.07 [1.03-1.11],0.0002623050115467
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23704,413,0.98 [0.88-1.08],0.6679633338350364
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23574,283,1.01 [0.90-1.14],0.8559353230807314
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23811,744,1.17 [1.09-1.25],7.517072826709978e-06
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",24082,69,1.17 [0.93-1.48],0.1706071781144787
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,22184,88,1.02 [0.83-1.27],0.8307084266202165
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23331,40,0.91 [0.66-1.27],0.5915806958357295
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23808,235,1.18 [1.04-1.33],0.0092825629738203
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22466,370,1.06 [0.95-1.17],0.2848620827287716
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,22142,46,1.05 [0.78-1.41],0.7509455951296474
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,24006,69,0.93 [0.73-1.19],0.5745102786339228
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,23202,135,1.04 [0.88-1.24],0.6388053324593829
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23894,150,1.28 [1.10-1.49],0.0011247660058537
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23617,44,1.15 [0.86-1.54],0.337550152135715
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,22154,58,0.92 [0.70-1.22],0.5685458287968279
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23506,1410,1.10 [1.05-1.16],0.0002129847228297
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22495,399,1.09 [0.98-1.20],0.0987401202503906
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,22146,50,1.05 [0.79-1.39],0.7536226571876411
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,24026,282,1.13 [1.01-1.27],0.0310598231011875
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23647,74,1.01 [0.80-1.28],0.9138862417837308
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23960,216,1.13 [0.99-1.29],0.0612434722594031
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,24051,244,1.01 [0.89-1.15],0.886929614863517
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22241,145,0.99 [0.84-1.18],0.9472267923932765
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22327,231,1.14 [1.00-1.29],0.0481329026895727
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,24039,232,0.99 [0.87-1.13],0.8906993780750356
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",22272,176,1.27 [1.10-1.45],0.0007561730219511
INSL5,Insulin-like peptide INSL5,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,24066,129,0.90 [0.75-1.08],0.2694086222610936
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20555,115,1.01 [0.83-1.22],0.932751916512822
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21886,5609,1.07 [1.04-1.10],1.6019922315487551e-06
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20659,4382,1.06 [1.03-1.09],8.165809444864043e-05
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20506,66,0.77 [0.59-1.01],0.0635755205326585
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20679,134,1.00 [0.84-1.19],0.9804512645605826
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20728,183,1.14 [0.99-1.32],0.0693730053581668
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23847,102,0.92 [0.75-1.12],0.3967199254225664
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20648,103,1.16 [0.96-1.40],0.1293263631435675
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17495,1218,1.03 [0.97-1.09],0.3402703083423685
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23957,202,1.07 [0.93-1.22],0.3617578341585531
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21058,513,1.06 [0.97-1.16],0.2011608917668486
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20248,7146,1.05 [1.02-1.07],7.103086006630454e-05
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,21583,122,1.13 [0.95-1.35],0.1679076568268467
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20561,121,1.06 [0.88-1.27],0.5365554276029008
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21052,612,0.95 [0.88-1.04],0.2634626043485783
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23195,2650,1.04 [1.00-1.09],0.0287694540454213
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20597,157,1.12 [0.95-1.30],0.1691857423861406
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20782,342,0.93 [0.83-1.04],0.1981665732294651
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20597,157,1.08 [0.92-1.27],0.3366886721821442
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23224,95,0.98 [0.79-1.21],0.8479454262740154
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17932,1655,1.04 [0.99-1.09],0.1028151846454782
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16461,184,1.66 [1.47-1.87],1.6903230035368595e-16
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",24085,181,1.70 [1.50-1.92],4.468227641167244e-17
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16371,94,1.12 [0.91-1.37],0.28746568603666
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16790,513,1.05 [0.97-1.15],0.2368337993857472
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20736,296,1.07 [0.95-1.20],0.2741894003444511
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16830,553,1.04 [0.96-1.14],0.3211316288475943
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20604,59,1.01 [0.78-1.32],0.9317071434147248
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21168,623,1.06 [0.98-1.15],0.1271504715502599
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20839,294,1.00 [0.89-1.12],0.9759542802150878
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16790,513,1.06 [0.98-1.16],0.1562895427223978
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20516,76,1.21 [0.98-1.50],0.0794014094020753
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20499,59,1.35 [1.07-1.71],0.0126085794375645
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,21506,45,1.20 [0.90-1.59],0.2117424848927238
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23679,2218,1.09 [1.05-1.14],5.404599607304091e-05
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23061,1600,1.09 [1.04-1.15],0.0004935347788633
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23917,522,1.13 [1.04-1.23],0.0042811795810475
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18956,2679,1.08 [1.04-1.12],6.661503194070212e-05
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,16339,62,1.07 [0.84-1.38],0.5778616222061266
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20530,90,1.22 [1.00-1.48],0.0495290388152887
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,16319,42,1.21 [0.91-1.62],0.1979541486503959
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16458,181,1.08 [0.94-1.25],0.2839729706402216
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21723,262,1.05 [0.93-1.18],0.4626093410810123
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,21962,501,1.08 [0.99-1.18],0.0772714983080073
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,24075,96,0.92 [0.74-1.14],0.4254948561900039
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22330,1785,1.04 [1.00-1.09],0.0709898051342318
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20554,114,1.02 [0.84-1.23],0.8543534642452446
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16486,209,1.00 [0.87-1.15],0.9700422913485522
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21259,714,1.02 [0.94-1.10],0.629698600494452
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18521,2244,1.06 [1.01-1.10],0.0110179212604648
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23244,115,1.00 [0.82-1.21],0.974995917403646
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,24080,73,1.01 [0.80-1.28],0.9327587510574183
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20505,65,1.17 [0.92-1.48],0.1956430729391317
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21744,1304,1.06 [1.01-1.12],0.0268551617065319
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20513,73,1.08 [0.86-1.36],0.4996816603420714
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18034,1757,1.09 [1.04-1.14],0.0005611567366209
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21590,129,1.08 [0.91-1.29],0.3630782338421613
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20489,49,0.76 [0.55-1.05],0.1004908213864042
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20720,175,1.24 [1.07-1.42],0.0033666004029886
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20948,508,1.09 [1.00-1.19],0.0461756991298125
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23586,457,1.00 [0.91-1.09],0.930497886716013
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21111,566,1.01 [0.93-1.10],0.8407288200727334
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23929,505,1.10 [1.01-1.20],0.0249265703764828
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,24072,59,1.34 [1.06-1.70],0.0133211782603669
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20639,199,0.98 [0.85-1.13],0.7611800078886584
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18484,801,1.09 [1.01-1.16],0.0205562183817878
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21030,590,1.04 [0.96-1.13],0.336668974723089
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20547,107,1.05 [0.86-1.27],0.6505696015502971
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",16350,73,1.14 [0.91-1.42],0.257829575688575
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18607,2330,1.10 [1.06-1.15],1.382216671018443e-06
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,17012,735,1.05 [0.98-1.13],0.1847835577867877
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23392,263,1.02 [0.90-1.16],0.7342708913525404
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",24050,71,0.93 [0.72-1.19],0.542733174638379
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",22077,48,1.16 [0.90-1.51],0.259140269798635
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,16351,74,1.04 [0.82-1.31],0.7493856394269671
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20645,100,1.12 [0.92-1.36],0.2487096357478952
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16803,526,1.15 [1.05-1.25],0.0014560319492403
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20725,285,1.06 [0.95-1.19],0.3113522414654937
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20796,251,1.03 [0.91-1.16],0.6820765091599527
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20787,242,1.08 [0.95-1.23],0.2239590260053369
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18584,77,1.17 [0.94-1.45],0.1687188725833345
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",24078,65,1.34 [1.07-1.67],0.0109812608116458
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20997,557,1.10 [1.02-1.20],0.018352013756441
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],23277,148,0.91 [0.76-1.08],0.269156782851105
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22928,2488,1.05 [1.01-1.09],0.0214288883153599
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20580,140,1.05 [0.89-1.24],0.5738969410062378
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21035,490,1.06 [0.97-1.16],0.2010993067453532
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22556,228,1.17 [1.03-1.33],0.014534218050684
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20764,219,1.00 [0.88-1.15],0.9552514042799628
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22072,1527,1.05 [1.00-1.10],0.0604516936301543
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21582,1037,1.00 [0.94-1.06],0.9982692214360968
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20495,55,1.28 [1.00-1.64],0.0472061965819196
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23342,213,0.94 [0.82-1.08],0.3985796584511142
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20615,175,0.87 [0.74-1.02],0.0894344709899085
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20559,119,0.98 [0.81-1.18],0.7983771230957187
INSL5,Insulin-like peptide INSL5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),16322,45,1.20 [0.91-1.59],0.1899845224103726
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Acute renal failure,23245,1046,1.29 [1.22-1.36],2.7736398939792176e-18
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),18029,87,0.98 [0.79-1.22],0.8522352775420217
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23494,102,1.03 [0.85-1.26],0.7579863346048133
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23960,203,1.07 [0.94-1.23],0.3118474890681795
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23780,23,1.05 [0.70-1.59],0.8079783839210165
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23375,1176,1.29 [1.22-1.36],3.155471171508968e-20
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23953,59,1.72 [1.39-2.12],3.64324376556046e-07
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23925,206,0.96 [0.83-1.11],0.5890800164522848
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Cystitis,21286,221,0.99 [0.86-1.13],0.8425631868578696
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Dialysis,22245,46,2.05 [1.63-2.57],9.194832116094083e-10
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23681,289,1.03 [0.92-1.16],0.5782840836518491
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Endometriosis,18092,150,0.91 [0.76-1.07],0.256706818429412
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",18284,342,1.02 [0.92-1.14],0.6670883928107372
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18819,877,0.93 [0.87-1.00],0.052482339079253
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18733,4353,1.07 [1.04-1.11],2.8032778290605386e-06
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23948,54,1.24 [0.97-1.59],0.0801432176137637
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,22081,182,1.19 [1.03-1.37],0.0165428928367953
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23611,354,1.08 [0.97-1.19],0.1629371726394515
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Irregular menses,23686,110,1.06 [0.88-1.28],0.5309277732224847
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Menorrhagia,18210,268,1.00 [0.89-1.13],0.9625110335845356
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,21132,67,0.77 [0.59-1.02],0.0668028831454735
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,20079,2137,1.02 [0.97-1.06],0.4892135797943284
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,18063,121,1.19 [1.00-1.41],0.0463431034229874
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",24089,57,0.83 [0.63-1.11],0.2190327369311018
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",24089,71,1.03 [0.81-1.30],0.8166792784544877
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23006,1941,1.05 [1.00-1.09],0.0499546078854395
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21478,413,0.99 [0.90-1.10],0.9159994690393276
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23493,101,1.03 [0.84-1.25],0.789302968754158
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,24046,327,1.09 [0.98-1.22],0.1074894439860255
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,24045,77,1.06 [0.85-1.33],0.5920256500623369
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22726,1661,1.04 [0.99-1.10],0.0800828238631353
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23439,182,1.03 [0.89-1.20],0.6698166912408359
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,18080,138,1.10 [0.93-1.30],0.2635999987150109
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",18284,342,1.03 [0.93-1.15],0.5732640362156511
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,18044,102,0.92 [0.75-1.14],0.4624343369998842
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,18126,184,0.96 [0.82-1.12],0.5880561074605442
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22126,227,1.21 [1.07-1.37],0.0032192501599424
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23826,107,1.25 [1.04-1.49],0.0147657493007671
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,18207,265,0.96 [0.84-1.09],0.4996847549371075
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,18031,89,1.23 [1.01-1.50],0.0397675577977056
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18503,561,1.00 [0.92-1.09],0.976631771674283
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,18083,141,1.07 [0.90-1.26],0.4444348317867475
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18458,516,1.06 [0.97-1.16],0.1693840888046763
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23928,34,1.17 [0.85-1.62],0.3300612822828598
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23947,2048,1.23 [1.18-1.28],7.564660427189701e-23
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",22043,144,1.16 [0.99-1.36],0.0755488652122933
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22279,80,1.33 [1.09-1.64],0.0057475175240707
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23788,31,1.27 [0.92-1.76],0.1478204629817514
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Urethral stricture,21193,128,1.04 [0.87-1.24],0.6894681822204619
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23990,233,1.06 [0.93-1.20],0.403019626509738
INSL5,Insulin-like peptide INSL5,Chapter XIV Diseases of the genitourinary system,Uterine polyps,18061,119,0.96 [0.80-1.16],0.6911515018216681
